Hudson Bay Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.2M Sell
295,100
-179,900
-38% -$14.2M 0.13% 176
2025
Q4
$37.6M Sell
475,000
-40,000
-8% -$3.01M 0.22% 152
2025
Q3
$33.7M Sell
515,000
-235,000
-31% -$11.5M 0.2% 154
2025
Q2
$29.6M Sell
750,000
-299,900
-29% -$9.81M 0.19% 158
2025
Q1
$31.7M Buy
1,049,900
+228,700
+28% +$7.49M 0.2% 188
2024
Q4
$28.7M Buy
821,200
+54,300
+7% +$2.03M 0.17% 195
2024
Q3
$30.7M Buy
766,900
+400,900
+110% +$18.7M 0.21% 125
2024
Q2
$17.4M Buy
366,000
+30,500
+9% +$1.25M 0.13% 151
2024
Q1
$14.5M Buy
335,500
+190,500
+131% +$9.08M 0.13% 134
2023
Q4
$7.34M Sell
145,000
-45,000
-24% -$2.16M 0.06% 239
2023
Q3
$8.62M Sell
190,000
-85,000
-31% -$3.51M 0.08% 183
2023
Q2
$11.3M Sell
275,000
-30,800
-10% -$1.18M 0.11% 156
2023
Q1
$10.9M Buy
305,800
+80,800
+36% +$3.03M 0.12% 155
2022
Q4
$8.5M Buy
225,000
+25,200
+13% +$1.06M 0.1% 213
2022
Q3
$8.84M Buy
199,800
+14,800
+8% +$624K 0.09% 208
2022
Q2
$6.85M Sell
185,000
-25,000
-12% -$943K 0.07% 302
2022
Q1
$7.78M Sell
210,000
-95,000
-31% -$3.11M 0.11% 209
2021
Q4
$9.28M Buy
305,000
+40,000
+15% +$1.26M 0.1% 157
2021
Q3
$8.89M Buy
265,000
+80,000
+43% +$3.01M 0.13% 163
2021
Q2
$7.38M Buy
185,000
+54,600
+42% +$2.14M 0.09% 212
2021
Q1
$5.86M Sell
130,400
-29,600
-19% -$1.65M 0.08% 241
2020
Q4
$9.05M Buy
160,000
+35,000
+28% +$1.74M 0.12% 127
2020
Q3
$5.93M Sell
125,000
-15,000
-11% -$833K 0.1% 204
2020
Q2
$8.25M Buy
140,000
+95,000
+211% +$5.28M 0.15% 124
2020
Q1
$2.13M Buy
45,000
+15,000
+50% +$836K 0.06% 258
2019
Q4
$1.81M Buy
+30,000
New +$1.79M 0.04% 293
2018
Q4
Sell
-40,000
Closed -$2.06M 872
2018
Q3
$2.06M Sell
40,000
-70,000
-64% -$3.29M 0.05% 462
2018
Q2
$4.58M Buy
110,000
+50,000
+83% +$2.22M 0.13% 309
2018
Q1
$2.65M Buy
+60,000
New +$3.05M 0.1% 390

Other funds holding IONS